These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19865839)

  • 1. Streptococcal protective antigens (Spa): a new family of type-specific proteins of group A streptococci.
    Ahmed EA; Penfound TA; Brewer SC; Tennant PA; Chiang EY; Dale JB
    Eur J Clin Microbiol Infect Dis; 2010 Jan; 29(1):51-7. PubMed ID: 19865839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group A streptococcus expresses a trio of surface proteins containing protective epitopes.
    Niedermeyer SE; Penfound TA; Hohn C; Li Y; Homayouni R; Zhao J; Dale JB
    Clin Vaccine Immunol; 2014 Oct; 21(10):1421-5. PubMed ID: 25080552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New protective antigen of group A streptococci.
    Dale JB; Chiang EY; Liu S; Courtney HS; Hasty DL
    J Clin Invest; 1999 May; 103(9):1261-8. PubMed ID: 10225969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.
    Courtney HS; Hasty DL; Dale JB
    Infect Immun; 2003 Sep; 71(9):5097-103. PubMed ID: 12933852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spa contributes to the virulence of type 18 group A streptococci.
    McLellan DG; Chiang EY; Courtney HS; Hasty DL; Wei SC; Hu MC; Walls MA; Bloom JJ; Dale JB
    Infect Immun; 2001 May; 69(5):2943-9. PubMed ID: 11292710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCR m typing: a new method for rapid typing of group a streptococci.
    Vitali LA; Zampaloni C; Prenna M; Ripa S
    J Clin Microbiol; 2002 Feb; 40(2):679-81. PubMed ID: 11825995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant tetravalent group A streptococcal M protein vaccine.
    Dale JB; Chiang EY; Lederer JW
    J Immunol; 1993 Aug; 151(4):2188-94. PubMed ID: 8345202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.
    Dale JB; Washburn RG; Marques MB; Wessels MR
    Infect Immun; 1996 May; 64(5):1495-501. PubMed ID: 8613352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.
    Villaseñor-Sierra A; McShan WM; Salmi D; Kaplan EL; Johnson DR; Stevens DL
    J Infect Dis; 1999 Dec; 180(6):1921-8. PubMed ID: 10558949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
    Bessen D; Fischetti VA
    J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses.
    Bronze MS; Courtney HS; Dale JB
    J Immunol; 1992 Feb; 148(3):888-93. PubMed ID: 1370521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and biological characterization of histidine triad protein in group A streptococci.
    Kunitomo E; Terao Y; Okamoto S; Rikimaru T; Hamada S; Kawabata S
    Microbes Infect; 2008 Apr; 10(4):414-23. PubMed ID: 18403236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci.
    Jones KF; Fischetti VA
    J Exp Med; 1988 Mar; 167(3):1114-23. PubMed ID: 2450950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytic, serological, and protective properties of streptococcal group A carbohydrate antibodies.
    Zabriskie JB; Poon-King T; Blake MS; Michon F; Yoshinaga M
    Adv Exp Med Biol; 1997; 418():917-9. PubMed ID: 9331798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments.
    Dale JB
    Vaccine; 1999 Jan; 17(2):193-200. PubMed ID: 9987154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and assessment of new vaccine candidates for group A streptococcal infections.
    McMillan DJ; Batzloff MR; Browning CL; Davies MR; Good MF; Sriprakash KS; Janulczyk R; Rasmussen M
    Vaccine; 2004 Jul; 22(21-22):2783-90. PubMed ID: 15246612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
    Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S
    BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M proteins of group G streptococci isolated from bacteremic human infections.
    Bisno AL; Craven DE; McCabe WR
    Infect Immun; 1987 Mar; 55(3):753-7. PubMed ID: 3102380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse-protective effect of rabbit anti-R-protein antibodies against group B streptococci type II carrying R-protein. Lack of effect on type III carrying R-protein.
    Lindén V
    Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):145-51. PubMed ID: 6346797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group A streptococcal antigens and vaccine potential.
    Kehoe MA
    Vaccine; 1991 Nov; 9(11):797-806. PubMed ID: 1722063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.